Ka On Lam

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Pembrolizumab Versus Paclitaxel, Gastrointestinal Oncology, Medicine +7

A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening

Helen H.N. Yan, Hoi Cheong Siu, Simon Law et al. · Cell stem cell · 2018 · 692 citations · Full text

Enables Therapeutic Screening, Oncology, Tumor Heterogeneity +9

Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure

Tai‐Chung Lam, K. C. TSANG, Cheuk‐Wai Choi et al. · Lung Cancer · 2021 · 69 citations

Medicine, Immunology, Combination Atezolizumab +9

Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis

Vincent Lai, Xiao Li, Victor Lee et al. · European Radiology · 2013 · 67 citations

Engineering, Medical Imaging, Post-chemoradiation Fibrosis +8

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma

Tsz Him So, Sik Kwan Chan, Wing‐Lok Chan et al. · Advances in Radiation Oncology · 2020 · 60 citations · Full text